Redwood Wealth Management Group’s Regenxbio RGNX Stock Holding History

Redwood Wealth Management Group’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,385	Closed	-$250K	–	187
2025 Q4	$250K	Buy	+17,385	New	+$217K	0.1%	155
2024 Q3	–	Sell	-13,360	Closed	-$156K	–	872
2024 Q2	$156K	Hold	13,360	–	–	0.12%	141
2024 Q1	$281K	Sell	13,360 -300	-2%	-$5.34K	0.3%	93
2023 Q4	$245K	Sell	13,660 -700	-5%	-$12.3K	0.27%	101
2023 Q3	$236K	Sell	14,360 -400	-3%	-$7.25K	0.28%	103
2023 Q2	$295K	Sell	14,760 -430	-3%	-$8.29K	0.33%	86
2023 Q1	$287K	Sell	15,190 -100	-0.7%	-$2.21K	0.33%	91
2022 Q4	$347K	Buy	+15,290	New	+$346K	0.43%	68

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Redwood Wealth Management Group's RGNX Position: Q1 2026 in Review

Redwood Wealth Management Group sold out of Regenxbio (RGNX) in Q1 2026, closing a stake of 17,385 shares — an estimated $250K sold.

Redwood Wealth Management Group first reported a position in RGNX in Q4 2022 and held it in 8 quarters. The position peaked at $347K in Q4 2022. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

Redwood Wealth Management Group reported no remaining Regenxbio position as of Q1 2026 after selling out during the quarter.
Redwood Wealth Management Group sold 17,385 Regenxbio shares in Q1 2026, an estimated $250K.
Redwood Wealth Management Group first reported a position in Regenxbio in Q4 2022 and held it in 8 quarters.
Redwood Wealth Management Group's Regenxbio position peaked at $347K in Q4 2022.
178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Redwood Wealth Management Group's 13F filing for Q1 2026, filed 24 Apr 2026.